Evidence map›Paper›PMID 42633405›Full record

ReviewEClinicalMedicine2026

Bone marrow failure syndromes across the age spectrum: diagnostic and therapeutic principles.

Jibran Durrani, Emma M Groarke, Mikkael A Sekeres

Abstract readReview
In one paragraph

Review in EClinicalMedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jibran DurraniSylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
Emma M GroarkeHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Mikkael A SekeresSylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone marrow failure syndromes (BMFS) are a diverse group of disorders that commonly present with pancytopenia and require a structured approach to evaluation. Initial assessment focuses on excluding reversible causes, followed by consideration of inherited and acquired conditions. Although the diagnostic approach is broadly similar across age groups, the underlying BMF etiology frequently differs: younger patients are more likely to have immune-mediated or inherited disease, whereas older adults more often have immune or clonal hematopoietic disorders. This review uses two age-defined cases to illustrate key diagnostic and management principles. Integration of clinical features, laboratory findings, and molecular testing is essential for accurate diagnosis. Timely referral to a hematologist and geneticist with expertise in bone marrow failure conditions can facilitate evaluation and multidisciplinary management. Careful classification, appropriate use of genetic testing, and ongoing monitoring are critical to guide treatment decisions, refine prognosis, and assess disease progression over time.

Indexed as

Aplastic anemiaClonal hematopoiesisGermline predispositionInherited bone marrow failure syndromesMyelodysplastic syndromesPancytopeniaSomatic mutations

Identifiers

PMID42633405
PMCPMC13499452

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.